Business
Publication of Circular
Immupharma PLC has announced the publication of a circular to shareholders, following its fundraising announcement on March 17, 2026. This circular details a General Meeting scheduled for April 7, 2026, at 11:00 a.m. GMT, where further resolutions related to the fundraising will be discussed. A copy of the circular will be available on the company's website. Disclaimer*
About this update from Immupharma Plc
[{"type":"text","content":"\n\n19 March 2026\n\n \nImmuPharma PLC\n(\"ImmuPharma\" or the \"Company\")\n \nPublication of Circular \n \nImmuPharma PLC (LSE:IMM), the specialist drug discovery and development company announces that further to its 'Fundraising' announcement, published on 17 March 2026 at 7:00 a.m. (the \"Fundraising RNS\"), a circular convening a General Meeting has today been sent to shareholders.\n \nThe General Meeting is scheduled to be held at 11.00 a.m. (GMT) on 7 April 2026, at the offices of Broadfield Law UK LLP, One Bartholomew Close, London EC1A 7BL.\n \nA copy of the Circular will be available shortly, in electronic form, for download on the Company's website www.immupharma.co.uk.\n \nTerms used but not defined in this announcement have the same meaning as set out in the Fundraising RNS.\n \nFor further information, please contact:\n \n\n\n\n\nImmuPharma PLC (www.immupharma.co.uk.)\nTim McCarthy, Chief Executive Officer\nLisa Baderoon, Head of Investor Relations\n \n\n\n+44 (0) 207 206 2650\n \n + 44 (0) 7721 413496\n\n\n\n\nSPARK Advisory Partners Limited (NOMAD)\nNeil Baldwin\n \n\n\n+44 (0) 203 368 3550\n\n\n\n\nStanford Capital Partners (Joint Broker)\nPatrick Claridge, Bob Pountney\n \n\n\n44 (0) 20 3650 3650\n \n \n\n\n\n\nSI Capital (Joint Broker)\nNick Emerson\n \n\n\n+44 (0) 1483 413500\n\n\n\n\n \n\n\n\n\n\n\n\nNotes to Editors\nAbout ImmuPharma PLC\nImmuPharma PLC (LSE AIM: IMM) is a specialty biopharmaceutical company that discovers and develops peptide-based therapeutics. The Company's portfolio includes novel peptide therapeutics for autoimmune diseases and anti-infectives.\nFor additional information about ImmuPharma please visit www.immupharma.co.uk.\nImmuPharma's LEI (Legal Entity Identifier) code : 213800VZKGHXC7VUS895.\n \n\n","length":5743,"tagName":"div"}]